Table 3_cAMP-MFN2 signaling suppresses cochlear cell senescence and age-related hearing loss.docx

Table 3_cAMP-MFN2 signaling suppresses cochlear cell senescence and age-related hearing loss.docx

Introduction<p>Age-related hearing loss (presbycusis) is the most common sensory deficit in the elderly, yet it lacks effective pharmacological treatments. The decline of the cyclic AMP (cAMP) signaling pathway is implicated in aging, but its functional role in the auditory system remains larg...

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Yu Liu (6938) (author)
Diğer Yazarlar:	Jinyuan Cao (11506260) (author), Jie Cui (198388) (author), Haitong Chen (20830751) (author), Shujing Qin (11862449) (author), Qi Li (67548) (author), Zhongwu Su (499868) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Genetic Immunology age-related hearing loss (ARHL) cAMP mitofusin2 mitochondrial dynamics inflammation
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Table 2_cAMP-MFN2 signaling suppresses cochlear cell senescence and age-related hearing loss.docx
Yazar:: Yu Liu (6938)
Baskı/Yayın Bilgisi: (2025)

Table 1_cAMP-MFN2 signaling suppresses cochlear cell senescence and age-related hearing loss.xlsx
Yazar:: Yu Liu (6938)
Baskı/Yayın Bilgisi: (2025)

Supplementary file 2_Lycii radicis cortex alleviates fibrosis in hiPSC-derived multilineage hepatic organoids via the cAMP-PKA pathway.docx
Yazar:: Junming Xu (1716112)
Baskı/Yayın Bilgisi: (2025)

Supplementary file 1_Lycii radicis cortex alleviates fibrosis in hiPSC-derived multilineage hepatic organoids via the cAMP-PKA pathway.zip
Yazar:: Junming Xu (1716112)
Baskı/Yayın Bilgisi: (2025)

Table 6_Global burden of hearing loss in people aged 60 years and older, 1990–2021: results from the global burden of disease study.xlsx
Yazar:: Zhi-qiang Zhang (4587796)
Baskı/Yayın Bilgisi: (2025)

Table 5_Global burden of hearing loss in people aged 60 years and older, 1990–2021: results from the global burden of disease study.xlsx
Yazar:: Zhi-qiang Zhang (4587796)
Baskı/Yayın Bilgisi: (2025)

Table 3_Global burden of hearing loss in people aged 60 years and older, 1990–2021: results from the global burden of disease study.xlsx
Yazar:: Zhi-qiang Zhang (4587796)
Baskı/Yayın Bilgisi: (2025)

Table 4_Global burden of hearing loss in people aged 60 years and older, 1990–2021: results from the global burden of disease study.xlsx
Yazar:: Zhi-qiang Zhang (4587796)
Baskı/Yayın Bilgisi: (2025)

Table 1_Global burden of hearing loss in people aged 60 years and older, 1990–2021: results from the global burden of disease study.docx
Yazar:: Zhi-qiang Zhang (4587796)
Baskı/Yayın Bilgisi: (2025)

Table 2_Global burden of hearing loss in people aged 60 years and older, 1990–2021: results from the global burden of disease study.xlsx
Yazar:: Zhi-qiang Zhang (4587796)
Baskı/Yayın Bilgisi: (2025)

Supplementary file 1_Global burden of hearing loss in people aged 60 years and older, 1990–2021: results from the global burden of disease study.docx
Yazar:: Zhi-qiang Zhang (4587796)
Baskı/Yayın Bilgisi: (2025)

Differential impact of EBOV and MARV on cAMP-mediated function in human gut organoids reveals region-specific loss of forskolin-induced swelling in HCOs.
Yazar:: Elizabeth Y. Flores (22676699)
Baskı/Yayın Bilgisi: (2025)

Elamipretide: First Approval
Yazar:: Matt Shirley (7340599)
Baskı/Yayın Bilgisi: (2025)

Table 1_Association of SII and SIRI with incidence of cardiovascular disease in cardiovascular-kidney-metabolic syndrome: a prospective cohort study.doc
Yazar:: Chen Pengfei (22675154)
Baskı/Yayın Bilgisi: (2025)

Image 3_Association of SII and SIRI with incidence of cardiovascular disease in cardiovascular-kidney-metabolic syndrome: a prospective cohort study.tif
Yazar:: Chen Pengfei (22675154)
Baskı/Yayın Bilgisi: (2025)

Image 4_Association of SII and SIRI with incidence of cardiovascular disease in cardiovascular-kidney-metabolic syndrome: a prospective cohort study.tif
Yazar:: Chen Pengfei (22675154)
Baskı/Yayın Bilgisi: (2025)

Image 1_Association of SII and SIRI with incidence of cardiovascular disease in cardiovascular-kidney-metabolic syndrome: a prospective cohort study.tif
Yazar:: Chen Pengfei (22675154)
Baskı/Yayın Bilgisi: (2025)

Image 2_Association of SII and SIRI with incidence of cardiovascular disease in cardiovascular-kidney-metabolic syndrome: a prospective cohort study.tif
Yazar:: Chen Pengfei (22675154)
Baskı/Yayın Bilgisi: (2025)

<b>Morin alleviates fructose-driven disturbance of podocyte mitochondrial energy metabolism by inhibiting AMPD activity to improve glomerular injury</b>
Yazar:: Luyi Huang (22583081)
Baskı/Yayın Bilgisi: (2025)

Additional file 12 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
Yazar:: Thomas C. Clark (13318734)
Baskı/Yayın Bilgisi: (2025)

Additional file 10 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
Yazar:: Thomas C. Clark (13318734)
Baskı/Yayın Bilgisi: (2025)

Additional file 9 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
Yazar:: Thomas C. Clark (13318734)
Baskı/Yayın Bilgisi: (2025)

Additional file 6 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
Yazar:: Thomas C. Clark (13318734)
Baskı/Yayın Bilgisi: (2025)

Additional file 4 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
Yazar:: Thomas C. Clark (13318734)
Baskı/Yayın Bilgisi: (2025)

Additional file 3 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
Yazar:: Thomas C. Clark (13318734)
Baskı/Yayın Bilgisi: (2025)

Additional file 2 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
Yazar:: Thomas C. Clark (13318734)
Baskı/Yayın Bilgisi: (2025)

Additional file 1 of Immune cell-resolved transcriptomics provides insights into the basis for variations of fish genetic resistance to viral disease
Yazar:: Thomas C. Clark (13318734)
Baskı/Yayın Bilgisi: (2025)

Table 1_Association between SQSTM1 dysregulation and risk in alopecia areata: a Mendelian randomization study.docx
Yazar:: Lifang Hu (841297)
Baskı/Yayın Bilgisi: (2025)

Table 1_Study on the effect of different types of sugar on proliferation and inflammatory in goose fatty liver.docx
Yazar:: Shuang Yi (8698824)
Baskı/Yayın Bilgisi: (2025)

Supplementary file 1_Adopting orphan receptors: zebrafish Tlr4 homologs mediate responses to group IX/X transition metals.docx
Yazar:: Aaron P.D. Fox (22686512)
Baskı/Yayın Bilgisi: (2025)

<b>Excessive Lipolysis and Inflammatory Response in Adipose Tissue Are Associated with Elevated Serum Growth Hormone in Dairy Cows with Clinical Ketosis</b>
Yazar:: Xinxing Gao (22653201)
Baskı/Yayın Bilgisi: (2025)

Table 1_Gut microbiota alterations and systemic inflammation in community-acquired pneumonia: a prospective gut-lung axis study.docx
Yazar:: Xue-Qin Yang (3494345)
Baskı/Yayın Bilgisi: (2025)

Table 7_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
Yazar:: Fuxing Lin (7418234)
Baskı/Yayın Bilgisi: (2025)

Table 1_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.docx
Yazar:: Fuxing Lin (7418234)
Baskı/Yayın Bilgisi: (2025)

Table 5_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
Yazar:: Fuxing Lin (7418234)
Baskı/Yayın Bilgisi: (2025)

Table 6_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
Yazar:: Fuxing Lin (7418234)
Baskı/Yayın Bilgisi: (2025)

Image 1_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.tif
Yazar:: Fuxing Lin (7418234)
Baskı/Yayın Bilgisi: (2025)

Image 2_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.tif
Yazar:: Fuxing Lin (7418234)
Baskı/Yayın Bilgisi: (2025)

Table 3_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
Yazar:: Fuxing Lin (7418234)
Baskı/Yayın Bilgisi: (2025)

Table 4_Antifungal mechanism and transcriptome analysis of Bacillomycin D-C16 against Fusarium oxysporum.xlsx
Yazar:: Fuxing Lin (7418234)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_l2aca1p6v1cf0kahugahr2f542